For the last 18–24 months, reported cannabis growth told an incomplete story.

Demand did not plateau.
It was fragmented — between hemp channels, illicit markets, and regulated operators.

Now, with the Farm Bill loophole closing, Virginia coming online, and rescheduling potentially closer to execution, the numbers begin to look different. And feel different.

This week we sit down with Trent Woloveck to discuss:

• Why leading with retail first changes everything
• The strategic tradeoffs of vertical integration
• What true cannabinoid demand actually looks like once distortion fades

Chapters

00:00 The Value of Vertical Integration in Cannabis

04:52 Market Dynamics and Capital Allocation

09:34 Virginia's Cannabis Market Evolution

19:04 Impact of Federal Rescheduling on Cannabis

24:38 M&A Challenges in the Cannabis Industry

31:34 Navigating Regulatory Complexities

39:39 The Future of the Cannabis Market

47:27 Looking Ahead: Jushi's Future and Industry Changes

Summary

In this conversation, Bryan Fields and Trent Woloveck discuss the complexities of the cannabis industry, focusing on vertical integration, market dynamics, and the impact of federal rescheduling. They explore the challenges of capital allocation, the evolution of the Virginia cannabis market, and the difficulties of mergers and acquisitions in a heavily regulated environment. The discussion highlights the importance of understanding market demands and the potential for growth as the industry continues to normalize and expand.

Guest Links

• https://jushico.com
• https://www.linkedin.com/company/jushi-inc/
• https://x.com/two3king

Our Links

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared global podcast

The Dime is a top 10 Cannabis Podcast

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube: The Dime

📸 Instagram: The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

If you doubled your marketing spend tomorrow, would you double your sales?

Most cannabis marketing does not fail because teams spend too little. It fails because marketing is asked to create success while known problems remain unfixed. That is why marketing is often the first thing cut when results stall.

What has changed is that modern tracking makes attribution clearer and easier than ever. Attribution means understanding which actions actually drive revenue, not just traffic or activity.

This week we sit down with John Shute to discuss:

• Why marketing gets blamed for upstream failures
• How attribution reveals what is actually working
• Where most teams are missing

Chapters

00:00 Navigating Budget Cuts in Cannabis Marketing

02:59 The Importance of Trackable Marketing Strategies

06:05 Understanding Consumer Behavior and Retention

08:53 Leveraging Data for Brand Growth

11:59 The Role of Email Marketing in Cannabis Brands

15:10 Product Quality and Consumer Safety

18:01 Narrowing Focus for Brand Success

23:26 Smart Growth Strategies in Cannabis Marketing

26:24 The Importance of Data-Driven Decisions

27:21 Closing the Gap: SEO and Market Positioning

30:27 Maximizing Marketing ROI

33:03 Understanding Marketing Attribution

36:14 Navigating Challenges in Client Relationships

39:19 The Complexity of Marketing in Cannabis

45:04 Community Engagement and Social Responsibility

Summary

In this conversation, John Shute discusses the challenges and strategies of marketing within the cannabis industry, particularly in the context of budget cuts. He emphasizes the importance of trackable marketing efforts, such as email marketing, and the need for brands to focus on consumer retention and data analytics. John also highlights the significance of building a strong brand identity and ensuring product quality and consumer safety. The discussion touches on the evolving landscape of cannabis marketing, the necessity for comprehensive audits, and the value of community engagement initiatives.

Guest Links

• https://x.com/johnshute_
• https://www.linkedin.com/in/john-shute-pufcreativ/
• https://www.instagram.com/pufcreativ/
• https://www.youtube.com/channel/UCY2pdmT1-QHKux8728PRy2A
• https://www.linkedin.com/company/pufcreativ
• https://pufcreativ.com/

Our Links

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared global podcast

The Dime is a top 10 Cannabis Podcast

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube: The Dime

📸 Instagram: The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Most cannabis automation fails for a simple reason.
It optimizes motion instead of understanding.

Automation executes. Robotics adapts.
That distinction matters in an industry where variability is unavoidable and capital is limited.

This episode breaks down why feedback loops matter more than machines, why fully automated facilities are still far off, and how teams should think about constraints before investing.

This week, we sit down with Nohtal Partansky to cover:

• Why automation breaks under variability
• Automation vs robotics, clearly defined
• How to avoid expensive missteps

Chapters

00:00 Understanding Automation in Cannabis Manufacturing

03:02 The Role of Robotics vs. Automation

05:45 Consultative Approach to Automation

08:54 Challenges in Cultivation Automation

11:59 Designing for Variability in Automation

15:01 Iterative Development and Customer Feedback

18:08 Identifying Design vs. Customer Issues

21:06 Adapting to Environmental Nuances

23:55 Conveying Value in Automation Solutions

27:09 Strategic Approaches to Automation in Supply Chain

30:10 Optimizing Pre-Roll Production Processes

33:44 Understanding Tolerance Levels in Manufacturing

36:39 Intellectual Property in the Cannabis Industry

42:26 Innovations in Cannabis Manufacturing

45:32 Challenges in Automation and Scaling

50:51 Improving Processes and Training in Cannabis Operations

Summary

In this conversation, Bryan Fields and Nohtal Partansky delve into the intricacies of automation and robotics within the cannabis manufacturing industry. They discuss the differences between fully automated and automated processes, the consultative approach to implementing automation, and the challenges faced in cultivation. The conversation highlights the importance of feedback loops in robotics, the iterative design process, and the need for a deep understanding of customer needs. They also touch on the significance of protecting intellectual property while fostering innovation in a rapidly evolving industry.

Guest Links

• https://www.instagram.com/sortingroboticsinc/
• https://www.youtube.com/@sortingrobotics
• https://www.linkedin.com/company/sortingrobotics/
• https://www.sortingrobotics.com/
• https://www.linkedin.com/in/nohtal/

Our Links

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared global podcast

The Dime is a top 10 Cannabis Podcast

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube: The Dime

📸 Instagram: The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Before CBD was discussed by a President in the Oval Office, it was a medical necessity.

The Charlotte Figi story is well documented — and powerful.
Not because it was emotional, but because it forced a serious medical conversation.

Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.

Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.

This week, we sit down with Bill Morachnick to break down:

• Why CBD earned acceptance through medical trust, not consumer marketing
• How physician comfort, reimbursement pathways, and standards changed the conversation
• CBD in the Oval Office — and what that signals for the future of cannabis

Chapters

00:00 Introduction to Charlotte's Web and Bill Morachnick

03:00 The Inspiring Story of Charlotte Figi

05:51 The Executive Order and Its Implications

08:59 The Role of Education in CBD Acceptance

12:12 Challenges and Misconceptions in the Cannabis Industry

15:03 The Future of CBD and Medical Recommendations

18:06 The Impact of Federal Reimbursement on CBD

21:08 Defloria and the Future of Cannabis Research

24:01 Navigating Regulatory Changes and Industry Challenges

27:03 The Importance of Quality and Consistency in CBD Products

30:02 The Potential for Pharmaceutical Collaborations

33:04 Looking Ahead: The Future of CBD and Cannabis

36:13 Final Thoughts and Audience Engagement

Summary

In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.

Guest Links:

• https://www.trycharlottesweb.com/
• https://www.charlottesweb.com/
• https://www.youtube.com/charlotteswebcbd
• https://www.instagram.com/charlotteswebcbd/
• https://www.linkedin.com/in/bill-morachnick-01318a6/
• https://www.linkedin.com/company/charlottesweb/

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared global podcast

The Dime is a top 10 Cannabis Podcast

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube: The Dime

📸 Instagram: The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Everyone wants their product and brand to be known for consistency .
Almost no one is willing to do the difficult work that makes consistency possible.

• This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down:
• Why most cannabis brands fail at scale — and how process control, not an artisanal mindset, determines who lasts
• How MariMed engineers consistency across states by centralizing inputs & testing aggressively,
• What it actually takes to make effects-based products consistent and repeatable

Chapters

00:00 Introduction to the Cannabis Industry and Edibles

03:05 The Evolution of Edibles: From Early Days to Now

06:01 Ensuring Consistency Across State Lines

09:09 Quality Control and Testing in Edibles

12:01 Consumer Education and Brand Trust

15:13 MariMed Brand Portfolio and Market Strategy

18:06 Role of R&D in Product Development

21:00 Future Trends and Innovations in Edibles

24:03 Building Relationships with Budtenders and Consumers

27:58 Exploring Cannabinoids: THCV and CBG Effects

30:06 Understanding Edible Experiences and Consumer Expectations

32:00 Responsible Product Development in the Cannabis Industry

33:52 Brand Strategy and Market Penetration in New States

35:51 Innovative Products: Vibations and Consumer Convenience

38:04 Navigating the Hemp Market and Brand Expansion

39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis

44:02 The Importance of Team and Company Culture

Guest Links:

• https://www.marimedinc.com/
• https://www.linkedin.com/company/marimed-inc/about/
• https://www.linkedin.com/in/ryan-crandall-43133b12/
• https://x.com/MariMed_Inc

Summary

In this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior.

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared global podcast

The Dime is a top 10 Cannabis Podcast

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube: The Dime

📸 Instagram: The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Schedule III isn’t the finish line.
It’s the starting gun.

The EO said a lot — but most operators aren’t ready for what it actually means.

This week we sit down with Zach Edge and Dr. Matthew Moore to break down:

• Why Schedule III is guidance, not rules — and why the real impact comes during rulemaking
• What GMP, CFR, and pharmaceutical-grade manufacturing will actually require from operators
• Which parts of the supply chain face the biggest disruption as cannabis moves forward

Chapters

00:00 Historic Changes in Cannabis Scheduling

03:13 The Impact of Hemp in the New Landscape

06:07 Strategic Shifts for Cannabis Operators

08:59 Navigating Regulatory Changes

11:58 The Role of Pharmacies in the New Market

15:04 Global Trade and Competition in Cannabis

17:53 Research Opportunities and Challenges

21:02 Veterans and the Future of CBD

24:02 The Supply Chain Dynamics

26:47 The Future of Hemp and CBD Products

29:56 Final Thoughts on the Cannabis Industry

Summary:

In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves.

Guest Links:

• https://www.linkedin.com/company/the-rho-advisory/
• https://www.linkedin.com/in/zach-edge/
• https://www.linkedin.com/in/mmoore09/

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared global podcast

The Dime is a top 10 Cannabis Podcast

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube: The Dime

📸 Instagram: The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.